Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 38
Court Sets Final Deadline for La. Vioxx Plaintiffs to File Paperwork
Ill. Plaintiff Seeks New Trial on Design Defect, Negligence Claims
N.J. Judge Denies Merck's Request for New Trial in 2 Vioxx Cases
N.J. Judge Orders Expedited Discovery in 250 Vioxx Cases
Pfizer Maintains Plaintiffs Failed to Plead Causation, Seeks Dismissal
Arthritis Drugs - Issue: 37
Judge to Plaintiff: Accept $1.6 Million Remittitur or Face New Trial
MDL Judge Denies Plaintiff's Motion to Dismiss Claims Without Prejudice
PSC Seeks Order Compelling Case-Specific Discovery in MDL Cases
